Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Yaritza, Peña"'
Autor:
Kenneth Kalunian, Susan Manzi, Amy H Kao, Eric F Morand, Brad H Rovin, Karen H Costenbader, Karin Tse, Laura Eve Schanberg, Yaritza Peña, Kathleen Arntsen, Kenneth Getz, Joan M Von Feldt, Erin Connolly-Strong, Sanjyot Sangodkar, Lauren Bloch, Bradley Dickerson, Sydney Evans, Sandra C Raymond, Angel Williams Derricott, David Zook, Timothy Franson, Leslie M Hanrahan
Publikováno v:
Lupus Science and Medicine, Vol 8, Iss 1 (2021)
The Addressing Lupus Pillars for Health Advancement (ALPHA) Project is a global consensus effort to identify, prioritise and address top barriers in lupus impacting diagnosis, care, treatment and research. To conduct this process, the ALPHA Project c
Externí odkaz:
https://doaj.org/article/5818f0eec0ce4fc69c7eeb81a3be9cc1
Publikováno v:
Therapeutic Innovation & Regulatory Science. 55:1193-1198
Interest in patient-centric initiatives to engage patients as partners in clinical research and inform drug development strategy, planning and execution has increased exponentially during the past decade. Adoption, use, organizational approach and in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca0cab26fe999d4681f06537ec5a759d
https://doi.org/10.1007/s43441-021-00289-6
https://doi.org/10.1007/s43441-021-00289-6
Publikováno v:
Therapeutic Innovation & Regulatory Science. 54:1541-1550
Tufts CSDD conducted a study to quantify the magnitude of participant subgroup demographic disparities in industry-funded pivotal trials and establish baseline participant diversity measures. Eleven years of data on pivotal trials of all novel drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6552d60d23f71fb85f5e65f55617860
https://doi.org/10.1007/s43441-020-00181-9
https://doi.org/10.1007/s43441-020-00181-9
Publikováno v:
Therapeutic Innovation & Regulatory Science. 54:1159-1165
Due to the extreme heterogeneity of lupus and the lack of consensus among stakeholders, pharmaceutical and biotechnology companies have had limited success in developing treatments for lupus. For this reason, the Lupus Foundation of America (LFA), re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c9a550cf3266b8103e89b45e70b56d5
https://doi.org/10.1007/s43441-020-00134-2
https://doi.org/10.1007/s43441-020-00134-2
Autor:
Yaritza Peña, Stella Stergiopoulos, Zachary Smith, Michael Wilkinson, Kenneth A. Getz, Maria I. Florez, Joseph A. DiMasi
Publikováno v:
Clinical Pharmacology & Therapeutics. 107:324-332
We gathered data from three pipeline databases and other public sources on development stage and clinical trial metrics for 1,914 investigational drugs, biologics, and vaccines and 2,769 clinical trials intended to treat a wide variety of infectious
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e9296004614359a52b36052185e0420
https://doi.org/10.1002/cpt.1627
https://doi.org/10.1002/cpt.1627
Autor:
Sandra Raymond, Joan M. Von Feldt, Laura E. Schanberg, Timothy Franson, Bradley Dickerson, Kenneth A. Getz, Amy H. Kao, Sanjyot Sangodkar, Victoria P. Werth, Kenneth C. Kalunian, Kathleen Arntsen, Leslie Hanrahan, Sang Cheol Bae, David Zook, Thomas Dörner, Erin Connolly-Strong, Lauren Bloch, Ian N. Bruce, Eric F Morand, Susan Manzi, Karen H. Costenbader, Brad H. Rovin, Sydney Evans, Karin Tse, Yaritza Peña, Angel Williams Derricott
Publikováno v:
Lupus Science & Medicine
Lupus Science and Medicine, Vol 8, Iss 1 (2021)
Lupus Science and Medicine, Vol 8, Iss 1 (2021)
The Addressing Lupus Pillars for Health Advancement (ALPHA) Project is a global consensus effort to identify, prioritise and address top barriers in lupus impacting diagnosis, care, treatment and research. To conduct this process, the ALPHA Project c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82ab5c2c008d268bf1e9e29fc8ccbdc3
https://pubmed.ncbi.nlm.nih.gov/33563729
https://pubmed.ncbi.nlm.nih.gov/33563729
Autor:
Yaritza Peña
Publikováno v:
Biomedical Journal of Scientific & Technical Research. 28
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::873eb601c143745e5a981d71d0728033
https://doi.org/10.26717/bjstr.2020.28.004677
https://doi.org/10.26717/bjstr.2020.28.004677
Publikováno v:
Clinical therapeutics. 41(8)
Purpose A growing number of biopharmaceutical companies have been implementing patient-centric initiatives (PCIs). The Drug Information Association (DIA) and the Tufts Center for the Study of Drug Development (CSDD) collaborated on a study to gather
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d93820ebc3d7b79d3cbd321459a8e8d5
https://pubmed.ncbi.nlm.nih.gov/31443914
https://pubmed.ncbi.nlm.nih.gov/31443914
Autor:
L. Bloch, B. Dickerson, J. Von Feldt, Thomas Dörner, Yaritza Peña, Leslie Hanrahan, Susan Manzi, Sandra Raymond, Karen H. Costenbader, Ian N. Bruce, Victoria P. Werth, Amy H. Kao, Kathleen Arntsen, Laura E. Schanberg, Eric F Morand, D. Zook, S-C Bae, Kenneth A. Getz, Brad H. Rovin, Karin Tse
Publikováno v:
Annals of the Rheumatic Diseases. 79:1957.1-1957
Background:The Addressing Lupus Pillars for Health Advancement (ALPHA) Project is a global consensus initiative to identify, prioritize and address top barriers in lupus drug development, clinical care and access to care. The Lupus Foundation of Amer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf23d4091f216a4799a435c8069524d5
https://doi.org/10.1136/annrheumdis-2020-eular.2871
https://doi.org/10.1136/annrheumdis-2020-eular.2871
Autor:
Sandra Raymond, Brad H. Rovin, Joan M. Von Feldt, Karin Tse, Kenneth A. Getz, Amy H. Kao, Karen H. Costenbader, Yaritza Peña, Eric F Morand, Laura E. Schanberg, Ian N. Bruce, Thomas Dörner, Sang Cheol Bae, Kathleen Arntsen, Susan Manzi, Leslie Hanrahan, Annick Anderson, Victoria P. Werth
Publikováno v:
Lupus Science & Medicine
ObjectiveLupus is a complex, heterogeneous autoimmune disease that has yet to see significant progress towards more timely diagnosis, improved treatment options for short-term and long-term outcomes, and appropriate access to care. The Addressing Lup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3b8d5772d152b26c6c80e5d076f9890
https://doi.org/10.1136/lupus-2019-000342
https://doi.org/10.1136/lupus-2019-000342